Implication of Interleukin (IL)-18 in the pathogenesis of chronic obstructive pulmonary disease (COPD)

Cytokine

Volumn 74, Issue 2, 2015, Pages 313-317

  Dima, Efrossini ^a   Koltsida, Ourania ^a   Katsaounou, Paraskevi ^a   Vakali, Sofia ^a   Koutsoukou, Antonia ^a   Koulouris, Nikolaos G ^a   Rovina, Nikoletta ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Chronic obstructive pulmonary disease; Inflammasome; Interleukin (IL) 18

Indexed keywords

COLONY STIMULATING FACTOR 1; CRYOPYRIN; GAMMA INTERFERON; INFLAMMASOME; INTERLEUKIN 17; INTERLEUKIN 18; PURINERGIC P2X7 RECEPTOR; INTERLEUKIN 18 PROTEIN, HUMAN; INTERLEUKIN 1BETA CONVERTING ENZYME;

CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE RELEASE; CYTOKINE RESPONSE; DISEASE ASSOCIATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IMMUNE RESPONSE; INFECTION SENSITIVITY; INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RESPIRATORY TRACT INFECTION; REVIEW; SMOKING; UPREGULATION; ANIMAL; DENDRITIC CELL; DISEASE MODEL; HELPER CELL; IMMUNOLOGY; LUNG; MACROPHAGE; MOUSE; PATHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ANIMALS; CASPASE 1; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-18; LUNG; MACROPHAGES; MICE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84940383566     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.04.008     Document Type: Review

References (75)

1. Rabe K.F., Hurd S., Anzueto A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 176:532-555.
2. Stockley R.A., Mannino D., Barnes P.J. Burden and pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009, 6:524-526.
3. Chung K.F., Adcock I.M. Multi-faceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008, 31:1334-1356.
4. Motz G.T., Eppert B.L., Sun G., et al. Persistence of lung CD8 T cell oligoclonal expansions upon smoking cessation in a mouse model of cigarette smoke-induced emphysema. J Immunol 2008, 181:8036-8043.
5. + T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med 2005, 172:590-596.
6. Baraldo S., Turato G., Badin C., et al. Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax 2004, 59:308-312.
7. 1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996, 51:267-271.
8. Barnes P.J., Shapiro S.D., Pauwels R.A. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003, 22(4):672-688.
9. Saetta M., Mariani M., Panina-Bordignon P., et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 165:1404-1409.
10. Jin Y., Wan Y., Chen G., et al. Treg/IL-17 ratio and Treg differentiation in patients with COPD. PLoS One 2014, 9(10):e111044.
11. Holtzman M.J., Byers D.E., Alexander-Brett J., et al. The role of airway epithelial cells and innate immune cells in chronic respiratory disease. Nat Rev Immunol 2014, 14(10):686-698.
12. McAleer J.P., Kolls J.K. Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense. Immunol Rev 2014, 260(1):129-144.
13. Rovina N., Koutsoukou A., Koulouris N.G. Inflammation and immune response in COPD: where do we stand?. Mediators Inflamm 2013, 2013:413735.
14. Brusselle G.G., Provoost S., Bracke K.R., et al. Inflammasomes in respiratorydisease: from bench to bedside. Chest 2014, 145(5):1121-1133.
15. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
16. Birrell M.A., Eltom S. The role of the NLRP3 inflammasome in the pathogenesis of airway disease. Pharmacol Ther 2011, 130(3):364-370.
17. Di Stefano A., Caramori G., Barczyk A., et al. Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. Thorax 2014, 69(6):516-524.
18. Franchi L., Munoz-Planillo R., Nunez G. Sensing and reacting to microbes through the inflammasomes. Nat Immunol 2012, 13(4):325-332.
19. Opitz B., van Laak V., Eitel J., et al. Innate immune recognition in infectious and non-infectious diseases of the lung. Am J Respir Crit Care Med 2010, 181:1294-1309.
20. Latz E. The inflammasomes: mechanisms of activation and function. Curr Opin Immunol 2010, 22(1):28-33.
21. Franchi L., McDonald C., Kanneganti T., et al. Nucleotide binding oligomerization domain-like receptors: intracellular pattern recognition molecules for pathogen detection and host defense. J Immunol 2006, 177:3507-3513.
22. Churg A., Zhou S., Wang R., et al. The role of interleukin 1-beta in murine cigarette smoke-induced emphysema and small airway remodeling. Am J Respir Cell Mol Biol 2009, 40:482-490.
23. Kang M., Homer R.J., Gallo A., et al. IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation. J Immunol 2007, 178. 3.
24. Sims J.E. IL-1 and IL-18 receptors, and their extended family. Curr Opin Immunol 2002, 14:117-122.
25. Dinarello C.A. IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999, 103(1 Pt 1):11-24.
26. Lee J.K., Kim S.H., Lewis E.C., et al. Differences in signaling pathways by IL-1beta and IL-18. Proc Natl Acad Sci USA 2004, 101(23):8815-8820.
27. Fantuzzi G., Dinarello C.A. Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). J Clin Immunol 1999 Jan, 19(1):1-11.
28. Lu A., Wu H. Structural mechanisms of inflammasome assembly. FEBS J 2014, 10.1111/febs.13133.
29. Vance R.E. The NAIP/NLRC4 inflammasomes. Curr Opin Immunol 2015 Feb, 32C:84-89. 10.1016/j.coi.2015.01.010.
30. Lechtenberg B.C., Mace P.D., Riedl S.J. Structural mechanisms in NLR inflammasome signaling. Curr Opin Struct Biol 2014 Dec, 29:17-25. 10.1016/j.sbi.2014.08.011.
31. Gutzmer R., Langer K., Mommert S., et al. Human dendritic cells express the IL-18R and are chemoattracted to IL-18. J Immunol 2003, 171(6363):49.
32. Gutzmer R., Margarete Lisewski M., Zwirner J., et al. Human monocyte-derived dendritic cells are chemoattracted to C3a after up-regulation of the C3a receptor with interferons. Immunology 2004, 111(4):435-443.
33. Ikawa K., Nishioka T., Yu Z., et al. Involvement of neutrophil recruitment and protease-activated receptor 2 activation in the induction of IL-18 in mice. J Leukoc Biol 2005, 78(5):1118-1126.
34. Sugawara S., Uehara A., Nochi T., et al. Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J Immunol 2001 Dec 1, 167(11):6568-6575.
35. Kim S.H., Reznikov L.L., Stuyt R.J., et al. Functional reconstitution and regulation of IL-18 activity by the IL-18R b chain. J Immunol 2001, 166:148.
36. Hong T.P., Andersen N.A., Nielsen K., et al. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma. Eur Cytokine Netw 2000 Jun, 11(2):193-205.
37. Hong T.P., Andersen N.A., Nielsen K., et al. Identification of a critical Ig-like domain in IL-18 receptor alpha and characterization of a functional IL-18 receptor complex. J Immunol 2003, 171(12):6574-6580.
38. Nakanishi K., Yoshimoto T., Tsutsui H., et al. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001, 19:423-474.
39. Fujibayashi Y., Fujimori Y., Kasumoto I., et al. Interleukin-18 regulates T helper 1 or 2 immune responses of human cord blood CD4+ V alpha 24+V beta 11+ natural killer T cells. Int J Mol Med 2007, 20(2):241-245.
40. Smeltz R.B., Chen J., Hu-Li J., et al. Regulation of interleukin (IL)-18 receptor alpha chain expression on CD4(+) T cells during T helper (Th)1/Th2 differentiation. Critical down regulatory role of IL-4. J Exp Med 2001 Jul 16, 194(2):143-153.
41. Freeman C.M., Han M.K., Martinez F.J., et al. Cytotoxic potential of lung CD8 (+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15. J Immunol 2010, 184(11):6504-6513.
42. Nakamura S., Otani T., Ijiri Y., Motoda R., Kurimoto M., Orita K. IFN-gamma-dependent and independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12. J Immunol 2000, 164(6):3330-3336.
43. Lee H.R., Yoon S.Y., Song S.B., et al. Interleukin-18-mediated interferon-gamma secretion is regulated by thymosin beta 4 in human NK cells. Immunobiology 2011 Oct, 216(10):1155-1162.
44. Srivastava S., Pelloso D., Feng H., et al. Effects of interleukin-18 on natural killer cells: co-stimulation of activation through Fc receptors for immunoglobulin. Cancer Immunol Immunother 2013 Jun, 62(6):1073-1082.
45. Gerdes N., Sukhova G.K., Libby P., et al. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002, 195(2):245-257.
46. Bellora F., Castriconi R., Doni A., Cantoni C., Moretta L., Mantovani A., et al. M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages. Eur J Immunol 2012, 42(6):1618-1626.
47. Hoshino T., Wiltrout R.H., Young H.A. IL-18 is a potent co-inducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol 1999, 162:5070-5077.
48. Hoshino T., Yagita H., Ortaldo J.R., et al. In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells. Eur J Immunol 2000, 30:1998-2006.
49. Lalor S.J., Dungan L.S., Sutton C.E., et al. Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gamma-delta and CD4 T cells that mediate autoimmunity. J Immunol 2011, 186(10):5738-5748.
50. Sutton C.E., Mielke L.A., Mills K.H. IL-17-producing γδ T cells and innate lymphoid cells. Eur J Immunol 2012, 42(9):2221-2231.
51. Dungan L.S., Mills K.H. Caspase-1-processed IL-1 family cytokines play a vital role in driving innate IL-17. Cytokine 2011, 56(1):126-132.
52. Wright J.L., Churg A. Animal models of cigarette smoke-induced chronic obstructive pulmonary disease. Expert Rev Respir Med 2010, 4(6):723-734.
53. Hoshino T., Kato S., Oka N., et al. Pulmonary inflammation and emphysema: role of the cytokinesIL-18and IL-13. Am J Respir Crit Care Med 2007, 176(1):49-62.
54. Kang M.J., Choi J.M., Kim B.H., et al. IL-18 induces emphysema and airway and vascular remodeling via IFN-γ, IL-17A, and IL-13. Am J Respir Crit Care Med 2012, 185(11):1205-1217.
55. Sakazaki Y., Hoshino T., Takei S., et al. Overexpression of chitinase 3-like 1/YKL-40 in lung-specific IL-18-transgenic mice, smokers and COPD. PLoS One 2011, 6(9):e24177.
56. Nikota J.K., Botelho F.M., Bauer C.M., et al. Differential expression and function of breast regression protein 39 (BRP-39) in murine models of subacute cigarette smoke exposure and allergic airway inflammation. Respir Res 2011, 12:39.
57. Takenaka S., Kawayama T., Imaoka H., et al. The progression of comorbidity in IL-18 transgenic chronic obstructive pulmonary disease mice model. Biochem Biophys Res Commun 2014 Mar 14, 445(3):597-601.
58. Feldman C., Anderson R. Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems. J Infect 2013, 67(3):169-184.
59. Kang M.J., Lee C.G., Lee, et al. Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest 2008, 118(8):2771-2784.
60. Motz G.T., Eppert B.L., Wortham B.W., et al. Chronic cigarette smoke exposure primes NK cell activation in a mouse model of chronic obstructive pulmonary disease. J Immunol 2010, 184(8):4460-4469.
61. Eltom S., Stevenson C.S., Rastrick J., et al. P2X7 receptor and caspase 1 activation are central to airway inflammation observed after exposure to tobacco smoke. PLoS One 2011, 6(9):e24097.
62. Mortaz E., Braber S., Nazary M., Givi M.E., Nijkamp F.P., et al. ATP in the pathogenesis of lung emphysema. Eur J Pharmacol 2009, 619:92-96.
63. Lucattelli M., Cicko S., Müller T., Lommatzsch M., de Cunto G., et al. P2X7 receptor signalling in the pathogenesis of smoke-induced lung inflammation and emphysema. Am J Respir Cell Mol Biol 2010, 44(3):423-429.
64. Eltom S., Belvisi M.G., Stevenson C.S., et al. Role of the inflammasome-caspase1/11-IL-1/18 axis in cigarette smoke driven airway inflammation: an insight into the pathogenesis of COPD. PLoS One 2014, 9(11):e112829.
65. Mohsenin A., Blackburn M.R. Adenosine signaling in asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 2006, 12(54-9):20.
66. Polosa R., Blackburn M.R. Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease. Trends Pharmacol Sci 2009, 30:528-535.
67. Lommatzsch M., Cicko S., Müller T., Lucattelli M., Bratke K., et al. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 181(928-934):22.
68. Cicko S., Lucattelli M., Müller T., Lommatzsch M., De Cunto G., et al. Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema. J Immunol 2010, 185:688-697.
69. Kratzer A., Salys J., Nold-Petry C., et al. Role of IL-18 in second-hand smoke-induced emphysema. Am J Respir Cell Mol Biol 2013, 48(6):725-732.
70. Matsuura H., Hartl D., Kang M.J., et al. Role of breast regression protein-39 in the pathogenesis of cigarette smoke-induced inflammation and emphysema. Am J Respir Cell Mol Biol 2011, 44(6):777-786.
71. Imaoka H., Hoshino T., Takei S., et al. Interleukin-18 production and pulmonary function in COPD. Eur Respir J 2008, 31(2):287-297.
72. Rovina N., Dima E., Gerassimou C., et al. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease. Respir Med 2009 Jul, 103(7):1056-1062.
73. Singh D., Fox S.M., Tal-Singer R., et al. Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers. Thorax 2011, 66(6):489-495.
74. Wang J., Liu X., Xie M., et al. Increased expression of interleukin-18 and its receptor in peripheral blood of patients with chronic obstructive pulmonary disease. COPD 2012, 9(4):375-381.
75. Rotta D.L., Rohmann K., Droemann D., et al. Nontypeable Haemophilus Influenzae infection upregulates the NLRP3 inflammasome and leads to caspase-1-dependent secretion of interleukin-1β - a possible pathway of exacerbations in COPD. PLoS One 2013, 8(6):e66818.